198 related articles for article (PubMed ID: 22022925)
1. Antipsoriatic drug development: challenges and new emerging therapies.
García-Pérez ME; Jean J; Pouliot R
Recent Pat Inflamm Allergy Drug Discov; 2012 Jan; 6(1):3-21. PubMed ID: 22022925
[TBL] [Abstract][Full Text] [Related]
2. Small molecules and antibodies for the treatment of psoriasis: a patent review (2010-2015).
Chiricozzi A; Saraceno R; Novelli L; Fida M; Caso F; Scarpa R; Costa L; Perricone R; Romanelli M; Chimenti S; Chimenti MS
Expert Opin Ther Pat; 2016 Jul; 26(7):757-66. PubMed ID: 27266423
[TBL] [Abstract][Full Text] [Related]
3. Advances in psoriasis physiopathology and treatments: Up to date of mechanistic insights and perspectives of novel therapies based on innovative skin drug delivery systems (ISDDS).
Sala M; Elaissari A; Fessi H
J Control Release; 2016 Oct; 239():182-202. PubMed ID: 27381248
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Occlusive and Open Application in a Psoriasis Plaque Test Design, Exemplarily Using Investigations of Mapracorat 0.1% Ointment versus Vehicle and Reference Drugs.
Wigger-Alberti W; Williams R; von Mackensen YL; Hoffman-Wecker M; Grossmann U; Staedtler G; Nkulikiyinka R; Shakery K
Skin Pharmacol Physiol; 2017; 30(2):102-114. PubMed ID: 28407625
[TBL] [Abstract][Full Text] [Related]
5. New topical treatments for psoriasis.
Chiricozzi A; Pitocco R; Saraceno R; Nistico SP; Giunta A; Chimenti S
Expert Opin Pharmacother; 2014 Mar; 15(4):461-70. PubMed ID: 24392930
[TBL] [Abstract][Full Text] [Related]
6. Antipsoriatic potential of Annona squamosa seed oil: An in vitro and in vivo evaluation.
Bhoir SS; Vishwapathi V; Singh KK
Phytomedicine; 2019 Feb; 54():265-277. PubMed ID: 30668377
[TBL] [Abstract][Full Text] [Related]
7. Plants and plant products with potential antipsoriatic activity--a review.
Kaur A; Kumar S
Pharm Biol; 2012 Dec; 50(12):1573-91. PubMed ID: 22971237
[TBL] [Abstract][Full Text] [Related]
8. Anti-cytokine therapy in the treatment of psoriasis.
Kupetsky EA; Mathers AR; Ferris LK
Cytokine; 2013 Mar; 61(3):704-12. PubMed ID: 23410503
[TBL] [Abstract][Full Text] [Related]
9. Emerging oral drugs for psoriasis.
Mahmood T; Zaghi D; Menter A
Expert Opin Emerg Drugs; 2015 Jun; 20(2):209-20. PubMed ID: 25643592
[TBL] [Abstract][Full Text] [Related]
10. Recent Advancements in Novel Formulations of Anti-psoriatic Agents for Effective Delivery: Clinical Importance and Patent Survey.
Dadwal N; Kurmi BD; Singh D; Singh A
Recent Pat Nanotechnol; 2024; 18(3):259-277. PubMed ID: 37264655
[TBL] [Abstract][Full Text] [Related]
11. Topical therapies for the treatment of plaque psoriasis.
Bagel J
Cutis; 2009 Oct; 84(4 Suppl):3-13. PubMed ID: 19916297
[TBL] [Abstract][Full Text] [Related]
12. Role of Apoptotic-targeted Phytoconstitutent-loaded Antipsoriatic Nanobiocomposites.
Singh Patel P; Srivastava R; Panchawat S
Recent Pat Nanotechnol; 2024; 18(2):220-236. PubMed ID: 36725825
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay.
Pol A; Bergers M; Schalkwijk J
In Vitro Cell Dev Biol Anim; 2003; 39(1-2):36-42. PubMed ID: 12892525
[TBL] [Abstract][Full Text] [Related]
14. The pharmacological management of patients with comorbid psoriasis and obesity.
Chiricozzi A; Gisondi P; Girolomoni G
Expert Opin Pharmacother; 2019 May; 20(7):863-872. PubMed ID: 30794469
[TBL] [Abstract][Full Text] [Related]
15. [Is the psoriasis plaque test still relevant in the age of biologicals?].
Wozel G
Hautarzt; 2006 Aug; 57(8):672-8. PubMed ID: 16855846
[TBL] [Abstract][Full Text] [Related]
16. Combining Topical Psoriasis Treatment to Enhance Systemic and Phototherapy: A Review of the Literature.
Bagel J; Gold LS
J Drugs Dermatol; 2017 Dec; 16(12):1209-1222. PubMed ID: 29240856
[TBL] [Abstract][Full Text] [Related]
17. Dihydrochalcone Derivatives from
Bélanger A; Grenier A; Simard F; Gendreau I; Pichette A; Legault J; Pouliot R
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905943
[TBL] [Abstract][Full Text] [Related]
18. A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studies.
Campa M; Menter A
Expert Opin Investig Drugs; 2016 Nov; 25(11):1337-1344. PubMed ID: 27687859
[TBL] [Abstract][Full Text] [Related]
19. Effects of nanoparticles with hydrotropic nicotinamide on tacrolimus: permeability through psoriatic skin and antipsoriatic and antiproliferative activities.
Wan T; Pan W; Long Y; Yu K; Liu S; Ruan W; Pan J; Qin M; Wu C; Xu Y
Int J Nanomedicine; 2017; 12():1485-1497. PubMed ID: 28260894
[TBL] [Abstract][Full Text] [Related]
20. New therapies under development for psoriasis treatment.
García-Pérez ME; Stevanovic T; Poubelle PE
Curr Opin Pediatr; 2013 Aug; 25(4):480-7. PubMed ID: 23838833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
